FDA has safety concerns with Merck insomnia drug

Home › FDA has safety concerns with Merck insomnia drug

The Food and Drug Administration on Monday released its review of the company's sleep aid, suvorexant, ahead of a public meeting on Wednesday.

02.07	Hurricane Beryl Graphics
02.07	Hurricane Beryl Forecast Discussion Number 15
02.07	Hurricane Beryl Wind Speed Probabilities Number 15
02.07	Hurricane Beryl Forecast Advisory Number 15
02.07	Hurricane Beryl Public Advisory Number 15
02.07	Summary for Hurricane Beryl (AT2/AL022024)
02.07	Levelling up: Can the next government help the UK games industry?
02.07	Cheap TVs ahead of Euros help slow price inflation
More »

je.st